Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. (Record no. 30483654)

MARC details
000 -LEADER
fixed length control field 02385 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518080106.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202008s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1879-0852
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ejca.2019.11.016
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ascierto, Paolo A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200803
245 00 - TITLE STATEMENT
Title Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of cancer (Oxford, England : 1990)
Date of publication, distribution, etc. 02 2020
300 ## - PHYSICAL DESCRIPTION
Extent 33-44 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzimidazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carbamates
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diarrhea
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nausea
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Outcome Assessment, Health Care
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins B-raf
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vemurafenib
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vomiting
General subdivision chemically induced
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dummer, Reinhard
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gogas, Helen J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Flaherty, Keith T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arance, Ana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mandala, Mario
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liszkay, Gabriella
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garbe, Claus
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schadendorf, Dirk
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krajsova, Ivana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gutzmer, Ralf
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de Groot, Jan Willem B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Loquai, Carmen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gollerkeri, Ashwin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pickard, Michael D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Robert, Caroline
773 0# - HOST ITEM ENTRY
Title European journal of cancer (Oxford, England : 1990)
Related parts vol. 126
-- p. 33-44
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ejca.2019.11.016">https://doi.org/10.1016/j.ejca.2019.11.016</a>
Public note Available from publisher's website

No items available.